Perceived Health After Hospitalization for COVID-19
PRO-COVID
1 other identifier
observational
207
1 country
1
Brief Summary
There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2021
CompletedFirst Submitted
Initial submission to the registry
June 2, 2021
CompletedFirst Posted
Study publicly available on registry
June 3, 2021
CompletedApril 15, 2022
April 1, 2022
11 months
June 2, 2021
April 14, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 disease
Through study completion, an average of 6 months
The value of perceived health scores in patients who achieved PASS and MCII
Through study completion, an average of 6 months
Study Arms (1)
COVID-19 Patient
Patient discharged from a conventional short-stay hospitalization unit.
Interventions
Eligibility Criteria
Patient with COVID-19 discharged from a conventional short-stay hospital ward.
You may qualify if:
- Adult patient
- Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan
- Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection
- Patient providing oral consent to participate in the study
- Patient able to understand and answer the questionnaires used
- Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS
- Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online
You may not qualify if:
- Patient under guardianship, curatorship or a measure of judicial safeguard
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Dijon Bourogne
Dijon, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2021
First Posted
June 3, 2021
Study Start
June 30, 2020
Primary Completion
May 22, 2021
Study Completion
May 22, 2021
Last Updated
April 15, 2022
Record last verified: 2022-04